Market revenue in 2023 | USD 14.3 million |
Market revenue in 2030 | USD 45.7 million |
Growth rate | 18.1% (CAGR from 2023 to 2030) |
Largest segment | Hemp |
Fastest growing segment | Hemp |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hemp, Marijuana |
Key market players worldwide | Medical Marijuana Inc, Canopy Growth Corp, Elixinol Wellness Ltd Ordinary Shares, The Cronos Group, Isodiol International Inc, Endoca, Folium Biosciences, NuLeaf Naturals, PharmaHemp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cannabidiol market will help companies and investors design strategic landscapes.
Hemp was the largest segment with a revenue share of 55.94% in 2023. Horizon Databook has segmented the Germany cannabidiol market based on hemp, marijuana covering the revenue growth of each sub-segment from 2018 to 2030.
Medical marijuana was legalized in 2017 in Germany. Unlike in some countries, patients in the country can access medical cannabis via prescription. The country has allowed around 20,000 pharmacies to sell medical cannabis by prescription. Germany was one of the first European countries to legalize medical cannabis and is a huge potential market for non-medical CBD.
According to German regulations, industrial hemp may be cultivated under stringent conditions. CBD may be extracted from domestically grown hemp or imported internationally, provided the THC content does not exceed 0.2%. CBD-derived edible products and oils are controlled by the German Federal Institute for Drugs and Medical Devices.
By April 2023, the German government declared that adults in the country will soon have the ability to cultivate and consume recreational cannabis privately or through nonprofit member clubs, which is expected to be implemented by year-end. This decision, made by the health minister, is seen as a departure from the previous strategy to sell the drug in shops or pharmacies nationwide.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany cannabidiol market , including forecasts for subscribers. This country databook contains high-level insights into Germany cannabidiol market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account